We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+14.4%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.47B
AUM Growth
-$383M
Cap. Flow
-$659M
Cap. Flow %
-26.68%
Top 10 Hldgs %
20.57%
Holding
503
New
157
Increased
65
Reduced
85
Closed
179

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$69.6M
2
LOW icon
Lowe's Companies
LOW
+$47.6M
3
NSC icon
Norfolk Southern
NSC
+$37.4M
4
HAS icon
Hasbro
HAS
+$36.3M
5
DLTR icon
Dollar Tree
DLTR
+$34.4M

Top Sells

Rank Stock Value
1
SN icon
SharkNinja
SN
+$69.8M
2
MSFT icon
Microsoft
MSFT
+$64.6M
3
DIS icon
Walt Disney
DIS
+$62.7M
4
KVUE icon
Kenvue
KVUE
+$48.3M
5
TGT icon
Target
TGT
+$44.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.49%
2 Technology 10.33%
3 Industrials 10.03%
4 Healthcare 8.86%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACDC icon
326
CALL
ProFrac Holding
ACDC
$744M
– –
-70,000
Closed -$364
ACRS icon
327
CALL
Aclaris Therapeutics
ACRS
$772M
– –
-128,200
Closed -$878K
ACRS icon
328
Aclaris Therapeutics
ACRS
$772M
– –
-11,456
Closed -$78.5K
ACRS icon
329
PUT
Aclaris Therapeutics
ACRS
$772M
– –
-66,000
Closed -$452K
AKRO
330
CALL
DELISTED
Akero Therapeutics
AKRO
– –
-20,500
Closed -$1.04M
AKRO
331
PUT
DELISTED
Akero Therapeutics
AKRO
– –
-27,000
Closed -$1.37M
AL
332
PUT
DELISTED
Air Lease Corp
AL
– –
-20,000
Closed -$788K
ALDX icon
333
CALL
Aldeyra Therapeutics
ALDX
$92.3M
– –
-101,200
Closed -$676K
ALDX icon
334
Aldeyra Therapeutics
ALDX
$92.3M
– –
-27,000
Closed -$180K
ALKS icon
335
Alkermes
ALKS
$8.31B
– –
-52,836
Closed -$1.48M
ALKS icon
336
PUT
Alkermes
ALKS
$8.31B
– –
-45,000
Closed -$1.26M
AMD icon
337
Advanced Micro Devices
AMD
$790B
– –
-49,205
Closed -$5.06M
AMLX icon
338
PUT
Amylyx Pharmaceuticals
AMLX
$2.24B
– –
-135,000
Closed -$2.47M
APLS
339
CALL
DELISTED
Apellis Pharmaceuticals
APLS
– –
-67,500
Closed -$2.57M
ARDX icon
340
PUT
Ardelyx
ARDX
$1.23B
– –
-968,100
Closed -$3.95M
ARKK icon
341
ARK Innovation ETF
ARKK
$5.84B
– –
-40,025
Closed -$1.59M
ARQT icon
342
CALL
Arcutis Biotherapeutics
ARQT
$3.24B
– –
-20,300
Closed -$108K
ASO icon
343
CALL
Academy Sports + Outdoors
ASO
$3.01B
– –
-361,300
Closed -$17.1M
ASRT
344
DELISTED
Assertio
ASRT
– –
-73,163
Closed -$2.81M
ATNM icon
345
Actinium Pharmaceuticals
ATNM
$25.5M
– –
-13,500
Closed -$79.9K
AUPH icon
346
PUT
Aurinia Pharmaceuticals
AUPH
$1.87B
– –
-92,800
Closed -$721K
AVDL
347
DELISTED
Avadel Pharmaceuticals
AVDL
– –
-163,382
Closed -$1.92M
AXP icon
348
PUT
American Express
AXP
$233B
– –
-12,600
Closed -$1.88M
AZN icon
349
CALL
AstraZeneca
AZN
$245B
– –
-61,250
Closed -$8.3M
AZN icon
350
PUT
AstraZeneca
AZN
$245B
– –
-13,100
Closed -$1.77M
12 13
14
15 16

Similar funds

CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return
PWP
Perfromance Wealth Partners Hinsdale, Illinois $3.45B AUM 29.14% 1-Year Est. Return
RBA
Richard Bernstein Advisors New York $3.45B AUM 16.24% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
LNC
Lincoln National Corp Radnor, Pennsylvania $3.45B AUM 12.55% 1-Year Est. Return
DAM
Davis Asset Management Sausalito, California $3.46B AUM 9.77% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return
MSC
MUFG Securities (Canada) New York $3.48B AUM 45.13% 1-Year Est. Return

J. Goldman & Co's Q4 2023 Portfolio in Review

As of Q4 2023, J. Goldman & Co held 503 positions worth $2.47B, down 13% from $2.85B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

J. Goldman & Co withdrew a net $659M in Q4 2023, closing 179 positions and reducing 85 holdings. Its most notable exit was Kenvue, an estimated $48.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

Against the trend, J. Goldman & Co opened a new position in Lowe's Companies worth $52.2M.

  • J. Goldman & Co's largest Q4 2023 buy was Lowe's Companies: 234,677 shares worth $52.2M.
  • J. Goldman & Co added most to PayPal in Q4 2023, an estimated $69.6M increase.
  • J. Goldman & Co's biggest Q4 2023 reduction was SharkNinja, cutting an estimated $69.8M.
  • J. Goldman & Co fully exited Kenvue in Q4 2023, selling an estimated $48.3M.
  • J. Goldman & Co's ten largest holdings make up 21% of its $2.47B portfolio in Q4 2023.
  • J. Goldman & Co opened 157 new positions and closed 179 in Q4 2023.
  • J. Goldman & Co's portfolio value fell 13% quarter-over-quarter to $2.47B.

Based on J. Goldman & Co's 13F filing for Q4 2023, filed 14 Feb 2024.